Menu Icon Search

COVID-19: GP Alert (12 October 2021)

October 12, 2021

UPDATED - Coronavirus Disease 2019 (COVID-19) SoNG v5.1

The Coronavirus Disease 2019 (COVID-19) CDNA National Guidelines for Public Health Units was updated on 8 October 2021. The latest update includes changes to contact management and casual contacts. More information is available online.

UPDATES – Third primary vaccine dose for immunocompromised

On Friday, the Australian Technical Advisory Group on Immunisation (ATAGI) have advised that a dose of a mRNA vaccine (Comirnaty (Pfizer) or Spikevax (Moderna)) is recommended for people who are severely immunocompromised, although AstraZeneca can be considered in some circumstances.
The third dose should be administered between 2 to 6 months after the second dose of vaccine. A minimum of 4 weeks may be considered in areas of COVID 19 outbreaks or intensification of immunosuppression.

Note that these are not considered boosters but are required for a specific cohort of vulnerable people to complete the regular course of COVID19 vaccination. You can read more here.

The CMO encourages GP’s to reach out to any of your immunocompromised patients who are who are fully vaccinated, to book them in for their third dose or provide them with evidence of the listed condition to receive the recommended third dose from a Vaccine provider.

NEW – PPE usage to step down to “low risk” in all QLD LGAs

From 4pm AEST Friday 8 October 2021, the six LGAs (Brisbane, Gold Coast, Logan City, Moreton Bay, Palm Island and Townsville including Magnetic Island) plus Redland City will return to "low risk" for PPE usage in all settings except fever clinics, which will remain at "moderate risk". More information on PPE usage for Queensland clinicians is available online.

PPE recommendation for GPs

General practices are encouraged to apply the PPE recommendations in accordance with Table 3 Healthcare settings. Please note that the Chief Health Officer Residential Aged Care Direction prevails when providing care in this setting.

NEW – Resources for the vaccination of adolescents

The National Centre for Immunisation Research and Surveillance (NCIRS) has developed a new resource answering some of the most frequently asked questions about COVID-19 in children, vaccines available in Australia, vaccine safety and schooling.

Queensland Adult Specialist Immunisation Service (QASIS)

QASIS provides specialist reviews and immunisation services for all Queensland adults who have experienced an adverse event following immunisation (AEFI) with a COVID-19 vaccine. QASIS also accepts referrals for adults who are identified as at risk of experiencing an adverse event following immunisation.

Who should be referred to QASIS?
Patients who are 16 years and older and who have experienced:

Refer a patient
Referrals can be sent to CPIU by:

  • Smart Referrals (if available at your practice)
  • Medical Objects – ID MQ40290004P

If unable to attached investigation or use secure messaging, fax to Central Patient Intake Unit (CPIU) on 1300 364 952

GP Referral Enquiry hotline (Central Patient Intake)
Monday – Friday, 8.30am – 5.00pm
1300 364 938

UPDATED – COVID vaccination during pregnancy – info for health professionals

COVID-19 vaccination at any stage of pregnancy is currently recommended by ATAGI, RANZCOG and Queensland Health.
To support health professionals and line managers regarding COVID vaccination during pregnancy current advice is now available at: